Boston Scientific Announces Japanese Approval for Drug-Eluting Stent System

Boston Scientific Corporation announced that it has received approval from the Japanese Ministry of Health, Labor and Welfare (MHLW) to market its TAXUS Liberte Paclitaxel-Eluting Coronary Stent System.
Yahoo! Finance